$79.97
+0 (+0%)
At Close: May 16, 2025
Inari Medical Announces Joint Venture in Greater China
04:05pm, Monday, 02'nd Dec 2024
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization
Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y
11:31am, Tuesday, 29'th Oct 2024
NARI's third-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the company continues to incur operating losses.
Inari Medical, Inc. (NARI) Q3 2024 Earnings Call Transcript
08:16pm, Monday, 28'th Oct 2024
Inari Medical, Inc. (NASDAQ:NARI ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Marissa Bych - VP, IR Drew Hykes - President and CEO Kevin Strange - CFO Tom Tu - C
Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates
06:56pm, Monday, 28'th Oct 2024
Inari Medical, Inc. (NARI) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago.
Inari Medical Reports Third Quarter 2024 Financial Results
04:05pm, Monday, 28'th Oct 2024
IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Okami Medical Announces Closing Of $32.5M Financing
01:00pm, Monday, 21'st Oct 2024
ALISO VIEJO, Calif. , Oct. 21, 2024 /PRNewswire/ -- Okami Medical today announced the closing of a $32.5M financing led by new investor Vensana Capital and joined by existing investors including U.S.
Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for
11:05am, Monday, 21'st Oct 2024
Inari Medical (NARI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
04:06pm, Monday, 07'th Oct 2024
IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Inari Medical to Announce Third Quarter 2024 Financial Results
04:05pm, Monday, 07'th Oct 2024
IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Inari Medical Inc (NARI) Shares Up 3.22% on Oct 2
12:11pm, Wednesday, 02'nd Oct 2024
Shares of Inari Medical Inc (NARI, Financial) surged 3.22% in mid-day trading on Oct 2. The stock reached an intraday high of $42.21, before settling at $41.94, up from its previous close of $40.63.
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
09:26am, Friday, 13'th Sep 2024
NARI continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
04:05pm, Thursday, 29'th Aug 2024
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering fro
Inari Medical (NARI) Issues Notice Post ClotTriever XL Recall
12:35pm, Monday, 26'th Aug 2024
Inari Medical (NARI) issues urgent updates to ClotTriever XL Catheter instructions following the FDA's recall after reports of serious injuries and deaths.
Inari Medical to Present at Upcoming Investor Conferences
04:05pm, Wednesday, 21'st Aug 2024
IRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Sign In
Buy NARI